SPY457.40+6.90 1.53%
DIA346.61+6.15 1.81%
IXIC15,381.32+127.27 0.83%

BRIEF-Allarity Plans To Submit Stenipafib Findings To U.S. NIH

reuters.com · 11/11/2021 02:35
BRIEF-Allarity Plans To Submit Stenipafib Findings To U.S. NIH

- Allarity Therapeutics A/S MDIPF:

  • REG-ALLARITY THERAPEUTICS’ ORAL PARP INHIBITOR, STENOPARIB, DEMONSTRATES PRE-CLINICAL ANTIVIRAL ACTIVITY AGAINST DELTA VARIANT OF CORONAVIRUS

  • PLANS TO SUBMIT FINDINGS TO U.S. NATIONAL INSTITUTES OF HEALTH (NIH) FOR FUNDING OPPORTUNITIES

Source text for Eikon: ID:nGNE5V5YZp

Further company coverage: MDIPF


(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))